Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2012 Mar;35(3):459-60.
doi: 10.2337/dc11-2441.

Dead or alive?

Carla J Greenbaum
Editorial

Dead or alive?

Carla J Greenbaum. Diabetes Care. 2012 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Eisenbarth GS. Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes. Diabetes 2010;59:759–774 - PMC - PubMed
    1. Greenbaum CJ, Mandrup-Poulsen T, McGee PF, et al. ; Type 1 Diabetes TrialNet Research Group; European C-Peptide Trial Study Group. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 2008;31:1966–1971 - PMC - PubMed
    1. Gottlieb PA, Quinlan S, Krause-Steinrauf H, et al. ; Type 1 Diabetes TrialNet MMF/DZB Study Group. Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new-onset type 1 diabetes. Diabetes Care 2010;33:826–832 - PMC - PubMed
    1. Keymeulen B, Vandemeulebroucke E, Ziegler AG, et al. Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 2005;352:2598–2608 - PubMed
    1. Ludvigsson J, Faresjö M, Hjorth M, et al. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008;359:1909–1920 - PubMed